Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries
AssigneeDeutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
InventorsAna Martin-Villalba, Peter Krammer, Deana Demjen
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of inhibitors of the CD95 ligand/receptor system for the manufacture of a medicament for the treatment of neurological disorders or injuries in a mammal, particularly for the treatment of spinal cord injury, more particularly for the treatment of paraplegia.
Claims29
Use of inhibitors of the CD95 ligand/receptor system for the manufacture of a medicament for the treatment of cerebral or spinal cord injury.
A method for treating cerebral or spinal cord injury comprising administering a therapeutically effective amount of an inhibitor of the CD95 ligand/receptor system to a subject in need thereof.
Dependencies are inferred from the claim text.